Загрузка...
Molecular biomarkers in early stage lung cancer
Low dose computed tomography (LDCT) screening, together with the recent advances in targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) survival. Furthermore, screening has increased the number of early stage-detected tumors, allowing for surgical resection and mul...
Сохранить в:
| Опубликовано в: : | Transl Lung Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947407/ https://ncbi.nlm.nih.gov/pubmed/33718054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-750 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|